This book provides a survey of recent advances in the development of
antibiofilm agents for clinical and environmental applications. The fact
that microbes exist in structured communities called biofilms has slowly
become accepted within the medical community. We now know that over 80%
of all infectious diseases are biofilm-related; however, significant
challenges still lie in our ability to diagnose and treat these
extremely recalcitrant infections.
Written by experts from around the globe, this book offers a valuable
resource for medical professionals seeking to treat biofilm-related
disease, academic and industry researchers interested in drug discovery
and instructors who teach courses on microbial pathogenesis and medical
microbiology.